Apr 26, 2024

Featuring perspectives from Dr Carlos M de Castro III, Prof Alexander Röth and Dr Ilene Ceil Weitz, including the following topics:

• Introduction: A Paroxysmal Nocturnal Hemoglobinuria (PNH) Audio Primer for General Medical Oncologists (0:00)
• Biology and Current Clinical Management of PNH (36:35)
• Future Directions in...

Apr 25, 2024

Featuring an interview with Dr Emmanuel S Antonarakis, including the following topics:

• Perspectives on advances in the management of prostate cancer over the last decade (0:00)
• Nonmetastatic high-risk prostate cancer and androgen deprivation therapy (ADT) intensification with abiraterone: Insights from the STAMPEDE...

Apr 24, 2024

Featuring perspectives from Dr Naveen Pemmaraju, including the following topics:

• Recent developments in management approaches for myelofibrosis prior to ASH 2023 (0:00)
• Updated data with navitoclax in combination with ruxolitinib for patients with myelofibrosis (12:35)
• Key findings with pelabresib in combination with...

Apr 19, 2024

Featuring perspectives from Dr Andrew H Ko and Dr Eileen M O’Reilly, including the following topics.

• Selection and Sequencing of Therapy for Patients with Metastatic Pancreatic Adenocarcinoma (PAD) — Dr Ko (0:00)
• Biomarker-Based Strategies for Metastatic PAD; Novel Investigational Approaches — Dr O’Reilly...

Apr 19, 2024

Featuring perspectives from Dr Kristen K Ciombor and Dr John Strickler, including the following topics.

• Select Biomarker-Directed Approaches for Colorectal Cancer (CRC) — Dr Ciombor (0:00)
• HER2-Targeted Approaches for Metastatic CRC (mCRC); Other Available and Emerging Therapeutic Strategies — Dr Strickler...